NYSE - Delayed Quote USD

Veeva Systems Inc. (VEEV)

200.91 +1.82 (+0.91%)
At close: April 26 at 4:00 PM EDT
200.71 -0.20 (-0.10%)
After hours: April 26 at 7:39 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
1/31/2024
1/31/2023
1/31/2022
1/31/2021
Total Revenue
2,363,673.00
2,363,673.00
2,155,060.00
1,850,777.00
1,465,069.00
Cost of Revenue
677,291.00
677,291.00
609,405.00
503,678.00
408,928.00
Gross Profit
1,686,382.00
1,686,382.00
1,545,655.00
1,347,099.00
1,056,141.00
Operating Expense
1,257,048.00
1,257,048.00
1,086,564.00
841,603.00
678,347.00
Operating Income
429,334.00
429,334.00
459,091.00
505,496.00
377,794.00
Net Non Operating Interest Income Expense
133,748.00
133,748.00
45,860.00
14,730.00
15,859.00
Other Income Expense
24,941.00
24,941.00
4,145.00
-7,915.00
340.00
Pretax Income
588,023.00
588,023.00
509,096.00
512,311.00
393,993.00
Tax Provision
62,318.00
62,318.00
21,390.00
84,921.00
13,995.00
Net Income Common Stockholders
525,705.00
525,705.00
487,706.00
427,390.00
379,998.00
Diluted NI Available to Com Stockholders
525,705.00
525,705.00
487,706.00
427,390.00
379,998.00
Basic EPS
3.27
--
3.14
2.79
2.52
Diluted EPS
3.22
--
3.00
2.63
2.36
Basic Average Shares
160,532.00
--
155,385.00
153,251.00
150,666.00
Diluted Average Shares
163,486.00
--
162,437.00
162,277.00
160,732.00
Total Operating Income as Reported
429,334.00
429,334.00
459,091.00
505,496.00
377,794.00
Total Expenses
1,934,339.00
1,934,339.00
1,695,969.00
1,345,281.00
1,087,275.00
Net Income from Continuing & Discontinued Operation
525,705.00
525,705.00
487,706.00
427,390.00
379,998.00
Normalized Income
525,594.14
525,594.14
487,139.82
427,985.65
377,803.81
Interest Income
133,748.00
133,748.00
45,860.00
14,730.00
15,859.00
Net Interest Income
133,748.00
133,748.00
45,860.00
14,730.00
15,859.00
EBIT
429,334.00
429,334.00
459,091.00
505,496.00
377,794.00
EBITDA
461,962.00
461,962.00
488,213.00
532,944.00
407,249.00
Reconciled Cost of Revenue
677,291.00
677,291.00
609,405.00
503,678.00
408,928.00
Reconciled Depreciation
32,628.00
32,628.00
29,122.00
27,448.00
29,455.00
Net Income from Continuing Operation Net Minority Interest
525,705.00
525,705.00
487,706.00
427,390.00
379,998.00
Total Unusual Items Excluding Goodwill
124.00
124.00
591.00
-714.00
2,275.00
Total Unusual Items
124.00
124.00
591.00
-714.00
2,275.00
Normalized EBITDA
461,838.00
461,838.00
487,622.00
533,658.00
404,974.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
Tax Effect of Unusual Items
13.14
13.14
24.82
-118.35
80.81
1/31/2021 - 10/16/2013

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

DOCS Doximity, Inc.
23.82
+0.97%
 
PGNY Progyny, Inc.
32.04
-1.42%
 
TDOC Teladoc Health, Inc.
13.01
-2.40%
 
TXG 10x Genomics, Inc.
27.59
+2.57%
 
GEHC GE HealthCare Technologies Inc.
86.24
+0.34%
 
SDGR Schrödinger, Inc.
23.97
+2.70%
 
GDRX GoodRx Holdings, Inc.
7.19
+1.55%
 
HQY HealthEquity, Inc.
80.26
+1.54%
 
SLP Simulations Plus, Inc.
44.69
-1.97%
 
CERT Certara, Inc.
16.57
+1.66%